Lurbe Empar, Redon Josep, Kesani Ajit, Pascual Jose Maria, Tacons Jose, Alvarez Vicente, Batlle Daniel
Pediatric Nephrology Unit, Department of Pediatrics, Hospital General and University of Valencia, Valencia, Spain.
N Engl J Med. 2002 Sep 12;347(11):797-805. doi: 10.1056/NEJMoa013410.
Patients with type 1 diabetes mellitus and microalbuminuria often have elevated blood pressure while they are asleep, but it is not known whether the elevation develops concomitantly with microalbuminuria or precedes it.
We monitored 75 adolescents and young adults who had had type 1 diabetes with normal urinary albumin excretion and blood pressure for more than five years. Ambulatory blood-pressure monitoring was used to assess blood pressure at the initial evaluation and about two years later, at which time all subjects had normal urinary albumin excretion. Subsequently, subjects were monitored for the development of microalbuminuria.
Microalbuminuria developed in 14 subjects, whereas the other 61 continued to have normal urinary albumin excretion. The mean (+/-SD) systolic pressure during sleep increased significantly in the subjects who ultimately had microalbuminuria (from 109.9+/-11.3 to 114.9+/-11.7 mm Hg, P=0.01) but not in the subjects with normal albumin excretion (from 106.0+/-8.8 to 106.4+/-14.8 mm Hg). The risk of progression to microalbuminuria was examined in relation to the ratio of systolic pressure during sleep to systolic pressure in the daytime. A ratio of 0.9 or lower, used to define a normal fall in nocturnal pressure, had a negative predictive value of 91 percent for the development of microalbuminuria. Moreover, the risk of microalbuminuria was 70 percent lower (95 percent confidence interval, 44 to 110 percent) in subjects with a ratio of 0.9 or less than in those with a ratio higher than 0.9 (P=0.01).
In persons with type 1 diabetes, an increase in systolic blood pressure during sleep precedes the development of microalbuminuria. In those whose blood pressure during sleep decreases normally, the progression from normal albumin excretion to microalbuminuria appears to be less likely.
1型糖尿病合并微量白蛋白尿的患者在睡眠期间常常血压升高,但尚不清楚这种血压升高是与微量白蛋白尿同时出现还是先于微量白蛋白尿出现。
我们对75例1型糖尿病患者进行了超过五年的监测,这些患者的尿白蛋白排泄和血压均正常。在初始评估时以及大约两年后使用动态血压监测来评估血压,此时所有受试者的尿白蛋白排泄均正常。随后,对受试者进行微量白蛋白尿发生情况的监测。
14名受试者出现了微量白蛋白尿,而其他61名受试者的尿白蛋白排泄仍保持正常。最终出现微量白蛋白尿的受试者睡眠期间平均(±标准差)收缩压显著升高(从109.9±11.3 mmHg升至114.9±11.7 mmHg,P = 0.01),而尿白蛋白排泄正常的受试者则无明显变化(从106.0±8.8 mmHg升至106.4±14.8 mmHg)。根据睡眠期间收缩压与白天收缩压的比值来检查进展为微量白蛋白尿的风险。比值为0.9或更低(用于定义夜间血压正常下降)时,对微量白蛋白尿发生的阴性预测值为91%。此外,比值为0.9或更低的受试者发生微量白蛋白尿的风险比比值高于0.9的受试者低70%(95%置信区间,44%至110%)(P = 0.01)。
在1型糖尿病患者中,睡眠期间收缩压升高先于微量白蛋白尿的出现。对于睡眠期间血压正常下降的患者,从正常白蛋白排泄进展为微量白蛋白尿的可能性似乎较小。